Corpus 1,273 assessed · 1,174 scored · 643 reproduced ≥75 · 169 flagged ·∅ 74.1/100

Publications 6 Datasets 392.5k Experiments 4.7k

Explore

Filters: IT ✕ 3 ✕ clear all

6 matching publication(s)

Publication	Journal	Year	Score	Verdict
Pleiotropic effects of MORC2 derive from its epigenetic signature PMID 40302207	—	2025	—	L1 No data access
Geometric Reliability of Super-Resolution Reconstructed Images from Clinical Fetal MRI in the Second Trimester. PMID 37284977	Neuroinformatics	2023	—	L1 No data access
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning. ⚑ PMID 36611079	NPJ Precis Oncol	2023	—	L1 No data access ⚑
Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. PMID 30578418	Nat Genet	2018	—	L1 No data access
The role of the multidisciplinary health care team in the management of patients with Marfan syndrome. PMID 27843325	—	2016	—	L1 No computation
Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation. PMID 19995790	—	2010	—	L1 No computation

Pleiotropic effects of MORC2 derive from its epigenetic signature

PMID 40302207 · · 2025

L1 No data access

Geometric Reliability of Super-Resolution Reconstructed Images from Clinical Fetal MRI in the Second Trimester.

PMID 37284977 · Neuroinformatics · 2023

L1 No data access

Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning.⚑

PMID 36611079 · NPJ Precis Oncol · 2023

L1 No data access ⚑

Trans-ethnic association study of blood pressure determinants in over 750,000 individuals.

PMID 30578418 · Nat Genet · 2018

L1 No data access

The role of the multidisciplinary health care team in the management of patients with Marfan syndrome.

PMID 27843325 · · 2016

L1 No computation

Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation.

PMID 19995790 · · 2010

L1 No computation